Compare GNTX & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNTX | HAE |
|---|---|---|
| Founded | 1974 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.8B |
| IPO Year | 1995 | 1996 |
| Metric | GNTX | HAE |
|---|---|---|
| Price | $21.11 | $119.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 11 |
| Target Price | $27.28 | ★ $120.00 |
| AVG Volume (30 Days) | ★ 2.0M | 591.4K |
| Earning Date | 10-23-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.00 | 0.72 |
| Revenue | ★ $2,534,268,965.00 | $910,373,000.00 |
| Revenue This Year | $5.41 | $6.27 |
| Revenue Next Year | $5.11 | $5.87 |
| P/E Ratio | ★ $21.15 | $165.93 |
| Revenue Growth | ★ 9.55 | N/A |
| 52 Week Low | $20.48 | $48.55 |
| 52 Week High | $26.96 | $121.00 |
| Indicator | GNTX | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 32.24 | 76.83 |
| Support Level | $20.48 | $72.93 |
| Resistance Level | $22.37 | N/A |
| Average True Range (ATR) | 0.41 | 3.02 |
| MACD | -0.07 | 0.80 |
| Stochastic Oscillator | 17.42 | 92.77 |
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion, with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.